Differences have been reported between the NSCLC subtypes adenocarcinoma and squamous cell carcinoma regarding perfusion related parameters [33] and staining of markers of hypoxia and metabolism (e.g. CAIX, GLUT-1) in pathological tumour specimens [43]. This evidence concerns the gene SLC2A1 and squamous cell carcinoma.